Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Vitamin C in Critically Ill Patients with Shock
NCT01587963Phase 2Terminated
- Sponsor
- Rutgers University
- Start
- Feb 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in Shock, sponsored by Rutgers University. Started Feb 2013; status: terminated.
02
Drugs
ascorbic acid
03
Conditions
Shock
Beyond the preview
Go deeper on NCT01587963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01587963.